Literature DB >> 755652

Cardiovascular changes in anaesthetised rats after the intra-hypothalamic administration of adrenaline.

K R Borkowski, L Finch.   

Abstract

Bilateral injections of adrenaline (0.01-10.0 microgram) into the anterior hypothalamic (AH) region, in urethane-anaesthetised spontaneous hypertensive (SH) rats, elicited dose-dependent falls in blood pressure and heart rate. The bradycardia was immediately in onset while the hypotension was preceded by a short-lasting rise in blood pressure. Bilateral injections of adrenaline into the anterior preoptic area (POA) and areas surrounding the AH had little or no effect on blood pressure and heart rate, while injections into the posterior hypothalamus (PH) induced tachycardia and hypertension followed by a smaller fall in blood pressure. Pretreatment with dl-propranolol (25-100 microgram bilat. AH) appeared to potentiate the hypotension induced by adrenaline (1 microgram bilat. AH) in a dose-dependent manner, but did not affect the falls in heart rate. On the other hand, pretreatment with metoprolol (25-100 microgram bilat. AH) effected a dose-dependent antagonism of the adrenaline-induced hypotension and bradycardia. Pretreatment with 1-propranolol (25 microgram bilat. AH) also antagonised the adrenaline-induced cardiovascular depressor effects, while pretreatment with d-propranolol (25 microgram bilat. AH) abolished the initial hypertensive effect. Pretreatment with piperoxan (25-100 microgram bilat. AH) antagonised adrenaline (1 microgram bilat. AH) induced hypotension and bradycardia only at the highest dose used. The results give further support to the concept that hypothalamic adrenaline receptors may be involved in the central regulation of blood pressure and heart rate. Furthermore, while an involvement of hypothalamic alpha-adrenoceptors cannot be ruled out, it is suggested that hypothalamic beta-adrenoceptors may be involved in mediating the cardiovascular depressor effects of adrenaline injected into the AH.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 755652     DOI: 10.3109/10641967809068609

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 0148-3927            Impact factor:   1.749


  4 in total

1.  Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure.

Authors:  Yu-Ming Kang; Ai-Qun Zhang; Xiu-Fang Zhao; Jeffrey P Cardinale; Carrie Elks; Xi-Mei Cao; Zhen-Wen Zhang; Joseph Francis
Journal:  Basic Res Cardiol       Date:  2011-02-02       Impact factor: 17.165

2.  Direct Corticosteroid Modulation of GABAergic Neurons in the Anterior Hypothalamic Area of GAD65-eGFP Mice.

Authors:  Seung Yub Shin; Tae Hee Han; So Yeong Lee; Seong Kyu Han; Jin Bong Park; Ferenc Erdelyi; Gabor Szabo; Pan Dong Ryu
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

3.  Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion.

Authors:  S L Lightman; K Todd; B J Everitt
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

Review 4.  Hypothalamic paraventricular nucleus activation contributes to neurohumoral excitation in rats with heart failure.

Authors:  Yu-Ming Kang; Qing Yang; Xiao-Jing Yu; Jie Qi; Yan Zhang; Hong-Bao Li; Qing Su; Guo-Qing Zhu
Journal:  Regen Med Res       Date:  2014-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.